Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748070 · ClinicalTrials.gov registry record · NA
Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT02748070: Completed NA study, sponsored by Stanford University.
NCT02748070 is a NA study that has completed, run by Stanford University. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748070, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
While oral steroids have been shown to be effective in the management of patients with chronic rhinosinusitis with polyps, its role in treating chronic rhinosinusitis without polyps (CRSsNP) is ambiguous. Despite a lack of strong clinical evidence to suggest a benefit in this disease state, steroids are often prescribed as a component of post-operative care after sinus surgery for patients without polyps. Oral steroids carry with them significant adverse effects, and should be prescribed thoughtfully. The aims of this study are to determine if oral steroids in the peri-operative period improves patient outcomes in CRS without polyps.
Interventions
- DRUG Prednisone
- DRUG Flonase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02748070
The ClinicalTrials.gov registry entry for NCT02748070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.
NCT02748070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02748070 about?
NCT02748070 is a clinical study titled "Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)". While oral steroids have been shown to be effective in the management of patients with chronic rhinosinusitis with polyps, its role in treating chronic rhinosinusitis without polyps (CRSsNP) is ambiguous. Despite a lack of strong clinical evidence to suggest a benefit in this disease state, steroids...
What is the current status of trial NCT02748070?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2015-08. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT02748070?
The interventions under investigation include: Prednisone (DRUG), Flonase (DRUG).
Who is sponsoring clinical trial NCT02748070?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.